1.40 USD
▲+0.05+5.26%
2026-08-03
市值
$120.73M
市盈率
—
EPS
-0.40
股息率
—
52 周区间
0.92 – 1.92
成交量
157.41K
Beta
3.29
目标价
3.83
52W 低 0.9252W 高 1.92
价格走势
公司简介
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutid...